DELUXE CORP (DLX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 800M 1.6B 2.4B FY08: 1.5B FY09: 1.3B FY10: 1.4B FY11: 1.4B FY12: 1.5B FY13: 1.6B FY14: 1.7B FY15: 1.8B FY16: 1.8B FY17: 2B FY18: 2B FY19: 2B FY20: 1.8B FY21: 2B FY22: 2.2B FY23: 2.2B FY24: 2.1B FY25: 2.1B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 500M 1B 1.5B FY08: 902.1M FY09: 839.4M FY10: 913.8M FY11: 924.2M FY12: 990.5M FY13: 1B FY14: 1.1B FY15: 1.1B FY16: 1.2B FY17: 1.2B FY18: 1.2B FY19: 1.2B FY20: 1.1B FY21: 1.1B FY22: 1.2B FY23: 1.2B FY24: 1.1B FY08 FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24

Operating Income Annual

-300M -150M 0 150M 300M 450M FY08: 209.2M FY09: 190.6M FY10: 281.5M FY11: 271.1M FY12: 302M FY13: 317.9M FY14: 332.6M FY15: 354.3M FY16: 366.9M FY17: 329.2M FY18: 231.2M FY19: -188.3M FY20: 40.7M FY21: 142.2M FY22: 169.4M FY23: 160.8M FY24: 192.2M FY25: 232.4M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-240M -160M -80M 0 80M 160M 240M FY08: 101.6M FY09: 99.4M FY10: 152.6M FY11: 144.6M FY12: 170.5M FY13: 186.7M FY14: 199.8M FY15: 218.6M FY16: 229.4M FY17: 230.2M FY18: 149.6M FY19: -223.8M FY20: 5.2M FY21: 62.6M FY22: 65.4M FY23: 26.1M FY24: 52.8M FY25: 82.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 400M 800M 1.2B FY08: 566.5M FY09: 504.8M FY10: 488.4M FY11: 493.4M FY12: 524.4M FY13: 561.1M FY14: 606.3M FY15: 639.2M FY16: 667.8M FY17: 742.7M FY18: 791.7M FY19: 812.9M FY20: 730.8M FY21: 884.3M FY22: 1B FY23: 1B FY24: 995.3M FY25: 1B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 150M 300M 450M FY08: 198.5M FY09: 206.4M FY10: 212.6M FY11: 235.4M FY12: 244.1M FY13: 261.5M FY14: 285.1M FY15: 309.6M FY16: 319.3M FY17: 338.4M FY18: 339.3M FY19: 286.7M FY20: 217.6M FY21: 210.8M FY22: 191.5M FY23: 198.4M FY24: 194.3M FY25: 270.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 100M 200M 300M FY10: 168.7M FY11: 199.9M FY12: 208.9M FY13: 224M FY14: 244M FY15: 266.4M FY16: 272.7M FY17: 291M FY18: 277.1M FY19: 220.1M FY23: 97.7M FY24: 100M FY25: 175.3M FY10 FY12 FY14 FY16 FY18 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 20M 40M 60M FY09: 50.9M FY10: 51.3M FY11: 51.4M FY12: 51.1M FY13: 51M FY14: 50.3M FY15: 49.8M FY16: 49M FY17: 48.4M FY18: 47M FY19: 43M FY20: 42.1M FY21: 42.8M FY22: 43.3M FY23: 43.8M FY24: 44.7M FY25: 45.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q4 '09: 1.94 Q1 '10: 2.35 Q2 '11: 2.97 Q3 '11: 2.70 Q4 '11: 2.80 Q1 '12: 3.03 Q2 '12: 3.17 Q3 '12: 3.27 Q4 '12: 3.32 Q1 '13: 3.35 Q2 '13: 3.47 Q3 '13: 3.58 Q4 '13: 3.65 Q1 '14: 3.69 Q2 '14: 3.74 Q3 '14: 3.70 Q4 '14: 3.96 Q1 '15: 3.94 Q2 '15: 4.06 Q3 '15: 4.31 Q4 '15: 4.35 Q1 '16: 4.62 Q2 '16: 4.69 Q3 '16: 4.75 Q4 '16: 4.66 Q1 '17: 4.64 Q2 '17: 4.68 Q3 '17: 4.08 Q4 '17: 4.72 Q1 '18: 4.87 Q2 '18: 4.90 Q3 '18: 3.64 Q4 '18: 3.14 Q1 '19: 2.76 Q2 '19: 2.26 Q3 '19: -4.56 Q4 '19: -4.75 Q1 '20: -7.13 Q2 '20: -7.53 Q3 '20: 0.66 Q4 '20: 0.18 Q1 '21: 2.20 Q2 '21: 2.13 Q3 '21: 1.71 Q4 '21: 1.45 Q1 '22: 1.10 Q2 '22: 1.32 Q3 '22: 1.38 Q4 '22: 1.50 Q1 '23: 1.34 Q2 '23: 1.21 Q3 '23: 0.69 Q4 '23: 0.59 Q1 '24: 0.77 Q2 '24: 0.86 Q3 '24: 1.24 Q4 '24: 1.18 Q1 '25: 1.25 Q2 '25: 1.29 Q3 '25: 1.83 Q4 '25: 1.81 Q1 '26: 2.27 Q2 '26: 2.18 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.